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ABSTRACT
Apurinic apyrimidinic endonuclease redox effector
factor-1 (APE1/Ref-1) is involved both in the base
excision repair (BER) of DNA lesions and in the
eukaryotic transcriptional regulation. APE1/Ref-1 is
regulated at both the transcriptional and post-
translational levels, through control of subcellular
localization and post-translational modification. In
response to stress conditions, several cell types
release ATP, whichexertsstimulatoryeffectsoneuka-
ryotic cells via the purinergic receptors (P2) family. By
using western blot and immunofluorescence analysis
on a human tumour thyroid cell line (ARO), we dem-
onstrate that purinergic stimulation by extracellular
ATP induces quick cytoplasm to nucleus transloca-
tion of the protein at early times and its neosynthesis
at later times. Continuous purinergic triggering
by extracellular ATP released by ARO cells is res-
ponsible for the control of APE1/Ref-1 intracellular
level. Interference with intracellular pathways
activated by P2 triggering demonstrates that Ca21
mobilization and intracellular reactive oxygen
species (ROS) production are responsible for APE1/
Ref-1 translocation. The APE1/Ref-1 activities on
activator protein-1 (AP-1) DNA binding and DNA
repair perfectly match its nuclear enrichment upon
ATP stimulation. The biological relevance of our
data is reinforced by the observation that APE1/
Ref-1 stimulation by ATP protects ARO cells by
H2O2-induced cell death. Our data provide new
insights into the complex mechanisms regulating
APE1/Ref-1 functions.
INTRODUCTION
Apurinic apyrimidinic endonuclease redox effector (APE1/
Ref-1) is a protein involved both in the BER pathways of
DNA lesions and in the regulation of gene expression as a
redox co-activator of different transcription factors, such as
Early growth response protein-1 (Egr-1), p53 and AP-1 (1).
These activities are located into two functionally distinct
domains: the N-terminus is principally devoted to the redox
activity while the C-terminus exerts the enzymatic activity on
the abasic sites of DNA (2).
APE1/Ref-1 is regulated at both the transcriptional and
post-translational levels. In terms of transcriptional regulation,
the effects of reactive oxygen species (ROS), such as H2O2,
O2
 and OH, on APE1/Ref-1 induction have been the most
intensively studied. Oxidative agents, such as H2O2, and ROS-
generating injuries, such as UV-radiation, promote a transient
APE1/Ref-1 induction, which correlates with an increase of its
endonuclease and redox activities (1). The post-translational
regulation of APE1/Ref-1 activities seems to reside into two
non-mutually exclusive mechanisms, i.e. subcellular localiza-
tion and post-translational modification degree. On one side,
APE1/Ref-1 undergoes an active cytoplasm to nucleus trans-
location in different cell types upon ROS exposure (3,4). On
the other side, phosphorylation and acetylation seem to play a
role in determining the functional activity of the protein
(1,5,6). However, neither molecular mechanisms responsible
for the induction of APE1/Ref-1 translocation upon oxidative
injury nor functional data regarding the ‘in vivo’ role played by
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post-translational modifications in controlling APE1/Ref-1
functions are clear (1). In particular, the ‘primum movens’ res-
ponsible for APE1/Ref-1 activation is completely unknown.
Since APE1/Ref-1 is critical for the survival of mammals
(7,8), it is important to dissect the signalling pathways
responsible for its regulation.
Most reports have localized APE1/Ref-1 into the nucleus,
but a growing body of evidence has shown that in some cell
types, particularly those with high metabolic or proliferative
rates, APE1/Ref-1 can be also cytoplasmic (1,3,4,9). Interest-
ingly, this is a typical feature of some human tumours (1), such
as the anaplastic thyroid carcinoma and the derived cell line
(i.e. ARO cells) (3,10).
Generally, stimuli that promote APE1/Ref-1 expression are
also able to promote its intracellular movement. The evidences
reporting APE1/Ref-1 subcellular re-localization upon a
stimulus have grown exponentially in the last few years (1).
Most of these are cytoplasm-to-nucleus translocations. Differ-
ent cellular conditions are able to perturb the APE1/Ref-1
intracellular localization (1); however, the way how euka-
ryotic cells regulate the re-localization of APE1/Ref-1 remains
a completely open question.
In response to stress conditions or other stimuli, such as
hypoxia, hyperoxia, mechanical stress, cAMP, hypotonic
media, vasoactive agents and inflammation, several cell
types release ATP via either a non-lytic (11,12) or a lytic
mechanism from necrotic and apoptotic cells, reaching high
local concentrations.
Extracellular nucleotides exert stimulatory effects on euka-
ryotic cells via the P2 family of membrane-bound receptors,
which comprises P2Y (G-protein-coupled) and P2X (ligand-
gated ion channel) receptors. Extracellular ATP improves the
mitogenic action of several growth factors in a variety of cell
types (13) through the control of transcriptional activators,
such as AP-1 (14,15) and Egr-1 via stimulation of P2Y recept-
ors (16). These effects are mainly played through the simul-
taneous increase of two important second messengers, Ca2+
ions and 1,2 diacylglycerol, a physiological activator of protein
kinase C (PKC) (17). Interestingly, there are strong evidences
demonstrating that the mitogenic action of P2Y triggering may
be exerted by intracellular ROS generation (18).
Therefore, in the light of these observations, we tested the
hypothesis of whether purinergic triggering may be able to
affect APE1/Ref-1 functions by controlling its expression and
subcellular localization.
MATERIALS AND METHODS
Cell culture and chemicals
ARO cells were cultured in RPMI medium containing
10% (w/v) fetal bovine serum (FBS), 5 mM glutamine and
antibiotics. HOBIT cells were grown in DMEM F-12
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal
calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin
and 10 mg/ml streptomycin sulfate. MG-63 osteoblast-like
cells were grown in DMEM culture medium containing
10% (w/v) FCS, 100 U/ml penicillin and 10 mg/ml streptomy-
cin sulfate. The cells were seeded in 100 mm dishes and grown
at 37C in a humidified atmosphere of 5% (v/v) CO2. Both
ATP and H2O2 treatments were performed on cells after 48 h
of serum starvation and in medium w/o serum. Where indic-
ated, protein neosynthesis was blocked by pre-treatment of the
cells for 5 min with cycloheximide (CHX) (15 mg/ml) and for
the whole duration of the experiment.
All the chemicals described below were from Sigma–
Aldrich Co. (St Louis, MO) unless otherwise specified.
Preparation of total and nuclear cell extracts
Cell nuclear extracts were prepared as described previously
(19). Briefly, 107 cells were washed once with phosphate-
buffered saline (PBS) and resuspended in 100 ml of hypotonic
lysis buffer A [10 mM HEPES, 10 mM KCl, 0.1 mM MgCl2,
0.1 mM EDTA, 2 mg/ml leupeptin, 2 mg/ml pepstatin and
0.5 mM phenylmethylsulfonyl fluoride (PMSF), pH 7.9].
After 10 min, cells were homogenized by 10 strokes with a
loose-fitting Dounce homogenizer. Nuclei were collected by
centrifugation at 500 · g at 4C for 5 min in a microcentri-
fuge. The supernatant was considered as the cytoplasmic frac-
tion. Nuclei were then washed three times with the same
volumes of buffer A in order to minimize cytoplasmic con-
tamination. Nuclear proteins were extracted with 100 ml of
buffer B (10 mM HEPES, 400 mM NaCl, 1.5 mM MgCl2,
0.1 mM EDTA, 2 mg/ml leupeptin, 2 mg/ml pepstatin and
0.5 mM PMSF, pH 7.9). After incubating for 30 min at 4C,
samples were centrifuged at 12 000 · g for 20 min at 4C.
Nuclear extracts were then analysed for protein content (20)
and stored at 80C in aliquots.
Western blot analysis
Aliquots containing 5 mg of both nuclear and cytoplasmic
extracts, obtained from ARO cells incubated under different
conditions, were electrophoresed onto a 12% SDS–PAGE.
Proteins were then transferred to nitrocellulose membranes
(Schleicher & Schuell, Keene, NH). Membranes were satur-
ated by incubation, at 4C overnight, with 5% non-fat dry milk
in PBS/0.1% Tween-20 and then incubated with the polyclonal
anti-APE1/Ref-1 antibody (21) for 3 h. After three washes
with PBS/0.1% Tween-20, membranes were incubated with
an anti-rabbit immunoglobulin coupled to peroxidase (Sigma,
St Louis, MO). After 60 min of incubation at room tem-
perature, the membranes were washed three times with
PBS/0.1% Tween-20 and the blots were developed using
enhanced chemiluminescence procedure (Amersham Pharma-
cia Biotech, Milan, Italy). Normalizations were performed
with the polyclonal anti-actin antibody (Sigma, St Louis,
MO). Blots were quantified by using a Gel Doc 2000
videodensitometer (Bio-Rad, Hercules, CA).
For western blot analysis of P2 receptors, 106 ARO cells
were lysed in 100 ml of lysis buffer containing 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT, 0.5 mM
PMSF, 0.1 mM NaF, 2 mg/ml leupeptin and 2 mg/ml pepstatin
in PBS. After incubation for 30 min on ice, cellular extracts
were centrifuged at 13 000 g for 15 min at 4C and the super-
natant was collected. Then, 50 mg of extracts were separated
onto a 10% SDS–PAGE, blotted onto nitrocellulose mem-
branes and assayed for the presence of P2Y1 and P2Y2 proteins
by using specific polyclonal antibodies (Alomone Labs.,
Jerusalem, Israel). To assay for the specificity of the recog-
nized bands, competition experiments, with the specific pep-
tides of the two receptors, were performed by pre-incubating
4380 Nucleic Acids Research, 2005, Vol. 33, No. 14
 at R
uth Lilly M
edical Library, Indiana U
niversity School of M
edicine on July 29, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
each antibody for 30 min at room temperature with each spe-
cific peptide according to manufacturer’s instructions before
probing the membranes. Membrane blocking and bands detec-
tion were performed as described above.
Immunofluorescence and confocal microscopy
Cells were fixed for 20 min with 4% paraformaldehyde in
PBS, treated for 5 min with 0.1% Triton X-100 in PBS.
Cells were then incubated for 30 min at 37C with 0.1 mg/ml
RNase in PBS. Unspecific binding of the antibodies was
blocked for 20 min with 1% FBS in PBS. The primary mono-
clonal antibody anti-APE1/Ref-1 (22) was incubated for
30 min at room temperature. Fluoresceinated secondary anti-
body was used to reveal the primary antibody.
After immunofluorescence treatment, nuclei were stained
by 3 min incubation in 1 mg/ml solution of propidium iodide in
PBS. Inhibition of protein synthesis was carried out by adding
CHX 5 min before and during the stimulation time. Immuno-
fluorescent images were collected using a confocal microscope
(Leica DM IRB/E, Wetzlar, Germany).
Determination of AP endonuclease activity
The determination of AP endonuclease activity was performed
using an oligonucleotide cleavage assay as described
previously (6). Cell extracts were incubated with a 50-32P-
end-labelled 26mer oligonucleotide containing a single
tetrahydrofuranyl (THF) artificial AP site at position 14,
which, in the presence of AP endonuclease activity, is cleaved
to a 14mer. The abasic analogue is resistant to cleavage by
30-acting AP lyase activity, which is generally possessed by
DNA glycosylase/AP lyases. Therefore, this assay is
specific for APE1/Ref-1 activity in cells. Reaction mixtures
(20 ml) containing cell extracts of interest, 2.5 pmol of 50-32P-
end-labelled, double-stranded THF oligonucleotide, 50 mM
HEPES, 50 mM KCl, 10 mM MgCl2, 1 mg/ml BSA and
0.05% Triton X-100 (pH 7.5) were allowed to proceed for
15 min in a 37C water bath. Reactions were halted by adding
10 ml of 96% formamide, 10 mM EDTA, xylene cyanol and
bromophenol blue as dyes. AP assay products (5 ml) were
separated on a 20% polyacrylamide gel containing 7 M
urea. Gels were wrapped in saran wrap and exposed to film
for autoradiography. The amount of 14mer–26mer was
determined by scanning the exposed film into Gel Doc scanner
(BioRad, Milan, Italy).
Electrophoretic mobility shift assay (EMSA)
analysis of AP-1 DNA-binding activity
Double-stranded oligodeoxynucleotides, labelled at the 50 end
with 32P, were used as probes in gel retardation assays. The
specific AP-1 consensus binding site, here named AP-1
BS oligonucleotide, is a 21mer whose upper strand is
50-CGCTTGATGAGTCAGCCGGAA-30. The mutant AP-1
binding site that was used for competitions, here named
AP-1 MS oligonucleotide, is a 21mer whose upper strand
is 50-CGCTTGATGACCCAGCCGGAA-30 (underlined the
mutagenized bases). Both oligonucleotides were from Geneka
Biotechnology Inc. (Montreal, Canada). The gel retardation
assay was performed by incubating protein and DNA in a
buffer containing 20 mM Tris–HCl, pH 7.6, 75 mM KCl,
0.25 mg/ml BSA with calf thymus DNA (25 mg/ml) and
10% glycerol for 30 min at room temperature. Protein-
bound DNA and free DNA were separated on a native 5%
polyacrylamide gel run in 0.5xTBE for 1.5 h at 4C. The gel
was dried and then exposed to an X-ray film at 80C.
Recombinant APE1/Ref-1 expression and purification
Recombinant APE1/Ref-1 protein (rAPE1/Ref-1) was
obtained as an hexahistidine-tag fusion protein from over-
expression in Escherichia coli and then purified by nickel-
chelate chromatography (23) from bacterial extracts and
treated as described previously (2). Sample concentrations
were determined by Bradford colorimetric assay (20). The
purified proteins gave a single band on an overloaded
SDS–PAGE. Fractions containing purified proteins were
stored at 80C. High-performance liquid chromatography
analysis and mass spectrometry characterization confirmed
the quality of the purified protein.
Cell viability assay
An MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide] assay was used for the cell viability
assay (24). After incubation with H2O2 for 1 h, a 1/10 volume
of MTT solution (4 mg/ml in PBS) was added and incubated
for 4 h under 10% CO2/90% air at 37
C. Then, the supernatant
was aspirated and an equal volume of dimethyl sulfoxide
was added to the cells; the MTT formazan was dissolved
by pipetting. The absorbance was measured on an enzyme-
linked immunosorbent assay plate reader (EL808 Ultra
Microplate Reader BIO-TEK Instruments, Inc., Winooski,
VT) with test and reference wavelength of 570 and 630 nm,
respectively.
Determination of intracellular ROS levels
Intracellular ROS levels were monitored by using the
fluorescent dye 20,70-dichlorodihydrofluorescein diacetate
(H2DCFDA) (Molecular Probes, Eugene, OR), which is a
non-polar compound converted into a non-fluorescent polar
derivative (H2DCF) by cellular esterases after incorporation
into cells. H2DCF is membrane impermeable and is oxidized
rapidly to the highly fluorescent 20,70-dichlorofluorescein
(DCF) in the presence of intracellular ROS (25). The day
before the experiments, ARO cells were seeded at a density
of 40 000 cells/cm2. In the day of the experiment, after remov-
ing the medium with serum, the cells were washed in the plates
with PBS and then incubated in 5% CO2/95% air at 37
C with
the ATP stimulus. Then, the H2DCFDA (10 mM) was added
30 min before finishing cellular treatment. The cells were
washed twice with PBS, harvested with trypsin and centri-
fuged at 800 g for 5 min and finally washed twice in PBS.
A spectrofluorometer (LS-50B Perkin Elmer, Wellesley,
MA) was used to measure the fluorescence intensity with
the excitation and emission wavelengths at 505 and 530 nm,
respectively.
RT–PCR analysis
Total RNA was purified from ARO or MG-63 cells using
the SV Total RNA Isolation System from Promega (WI,
USA) according to the manufacturer’s protocol. RT–PCR
was performed with 1 mg of total RNA as template. P2Y1,
P2Y2, P2Y4, P2Y6 and control GAPDH mRNAs were reverse
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transcribed using a 20mer oligo(dT) and amplified using the
specific primers: P2Y1 forward, 5
0-TGTGGTGTACCCCC-
TCAAGTCCC-30 and P2Y1 reverse, 50-ATCCGTAACAGC-
CCAGAATCAGCA-30 (amplified of 259 bp) (14); P2Y2
forward, 50-CCAGGCCCCCGTGCTCTACTTTG-30 and
P2Y2 reverse, 5
0-CATGTTGATGGCGTTGAGGGTGTG-30
(amplified of 362 bp) (14); P2Y4 forward, 5
0-CAGCAA-
CAAAGGGACCAC-30 and P2Y4 reverse, 50-GCTTGCCAC-
CACCACAGA-30 (amplified of 449 bp); P2Y6 forward,
50-ACAGGCATCCAGCGTAAC-30 and P2Y6 reverse, 50-
CGGACACAATGGCAAATA-30 (amplified of 530 bp) (26);
GAPDH forward 50-TCTAGACGCCAGGTCAGGTCCACC-
3 and GAPDH reverse 50-CCACCCATGGCAAATTCCAT-
GGCA-30 (amplified of 598 bp) (26). The amplified products
were resolved on a 1.5% agarose gel.
Statistical analysis
Statistical analysis was performed using the Microsoft excel
data analysis program for Student’s t-test analysis or the
statistical analysis program for ANOVA with the Scheffe`
multiple comparison test. P < 0.05 was considered statistically
significant.
RESULTS
ATP treatment modulates APE1/Ref-1 expression
and trafficking
The ARO cell line is ideal for the study of APE1/Ref-1
subcellular localization as these cells present a huge amount
of cytoplasmic APE1/Ref-1 (3,10). This allows monitoring
and characterizing the APE1/Ref-1 cytoplasm to nucleus
translocation at early times upon a stimulus. In order to follow
the APE1/Ref-1 trafficking upon ATP stimulation, we per-
formed western blot analysis after the separation of nuclear
and cytoplasmic compartments. The time course of ATP
stimulation demonstrates that the amount of APE1/Ref-1 in
the nuclear compartment increases following 10 min of ATP
(100 mM) stimulation and this increase persists until 60 min of
stimulation (Figure 1A). On the contrary, we found a strong
decrease of APE1/Ref-1 in the cytoplasmic fraction upon
10 min of ATP stimulation, followed by a new increase upon
30 min of ATP stimulation (Figure 1A). Indirect immunofluor-
escence experiments and confocal analysis (Figure 1B) were
in agreement with the western blot data. These data suggest
that ATP stimulation induced at least two events: first a
nuclear translocation of APE1/Ref-1 then a neosynthesis of
Figure 1. ATP affects both APE1/Ref-1 localization and expression. (A) ARO cells were cultured in serum-free medium for 48 h and then stimulated with ATP for the
indicated times. Representative western blot analysis, performed as described in Materials and Methods, of APE1/Ref-1 expression levels of nuclear and cytoplasmic
extracts of ARO cells stimulated for the indicated times with 100 mM ATP in the absence or in the presence of the protein synthesis inhibitor CHX (15 mg/ml) 5 min
before and during the ATP treatment, as indicated. Actin was always measured, as loading control. Lower panel, values obtained from densitometric analysis of three
independent western blot experiments were reported as histograms. Columns and bars indicate the means ± SD from three independent experiments. Black bars
represent the nuclear levels of APE1/Ref-1 and the white dotted bars represent the cytoplasmic APE1/Ref-1 protein levels obtained from densitometric analysis of
three independent experiments, normalized versus actin (*, p < 0.05; **, p < 0.001 compared with controls). (B) ARO cells were cultured in serum-free medium for
48 h and then stimulated with ATP for the indicated times. Cells were then fixed and stained for APE1/Ref-1 (green). Nuclei were visualized by propidium iodide
counterstaining (red). Note that APE1/Ref-1 is mainly nuclear upon 10 min of stimulation.
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APE1/Ref-1 protein at later times of stimulation. This was
confirmed by inhibiting the protein synthesis apparatus with
15 mg/ml CHX, 5 min before and during the whole duration of
the ATP stimulation time. The western blot analysis of the
cytoplasmic fraction showed that APE1/Ref-1 was undetect-
able at each time of ATP stimulation in the presence of CHX
(Figure 1A), suggesting that a later event of ATP stimulation is
the induction of APE1/Ref-1 protein neosynthesis.
As for the trafficking of APE1/Ref-1, we treated the cells
with CHX both in the presence and in the absence of ATP
stimulation; then, we followed APE1/Ref-1 localization by
western blot and confocal analysis. We found that following
ATP stimulation the amount of nuclear APE1/Ref-1 increased,
while it was undetectable in the cytoplasm (Figure 2A and B).
An opposite situation was observed following treatment with
CHX in the absence of ATP treatment. We found that 60 min
of CHX treatment produced a decrease of APE1/Ref-1 in the
nucleus and an increase in the cytoplasm where most of the
protein is localized (Figure 2A and B). We hypothesized that
APE1/Ref-1 redistribution represents the turn over of the pro-
tein, which becomes cytoplasmic and is further degraded. To
test this hypothesis, we analysed the half-life of APE1/Ref-1
both in the presence and in the absence of ATP by treating the
cells with CHX for different times. By western blot analysis of
total cellular extracts, we found that ATP stimulation did not
affect APE1/Ref-1 turn over (half-life), since the amount of
this protein did not change significantly within 6 h of CHX
treatment both in the presence and in the absence of ATP (data
not shown). All these data demonstrated that ATP stimulation
induced both APE1/Ref-1 translocation and its maintenance in
the nucleus.
In order to assay for the sensitivity of APE1/Ref-1 nuclear
translocation upon ATP stimulation, dose–response experi-
ments were carried out at 10 min of ATP treatment
(Figure 2C, lanes 1–4). Stimulatory effects were clearly
detectable at doses of ATP as low as 10 and 1 mM, thus
emphasizing the biological relevance of this phenomenon.
Purinergic receptors (P1 and P2) are natural candidates as
targets for ATP stimulation. To test whether ATP activates P2-
type receptors, ARO cells were pre-treated with P2 antagonist
(100 mM suramin) 30 min before the addition of 100 mM ATP
(27). Pre-treatment completely blocked the APE1/Ref-1 cyto-
plasm to nucleus translocation (Figure 2C, lanes 5 and 6),
underlining the role of cell-surface P2 purinergic receptors
in the extracellular ATP-mediated activation of APE1/Ref-1
in ARO cells.
Adenosine is the main agonist of P1 receptors (27) and it
may be present in the medium as a by-product of ATP hydro-
lysis. Therefore, we performed experiments with the non-
hydrolysable form of ATP (i.e. ATP-gS) and with adenosine.
Data reported in Figure 2C (lane 7) clearly show that exposure
of ARO cells to 100 mM ATP-gS promotes active APE1/Ref-1
nuclear translocation. On the contrary, adenosine treatment
did not exert any effect in determining APE1/Ref-1 translo-
cation definitely excluding any role for P1 receptors (lane 8).
To infer the class of P2 receptors (P2X or P2Y) that may be
responsible for the ATP-induced APE1/Ref-1 nuclear trans-
location, we performed a series of experiments with P2Y
specific agonists, UTP and ADP (27), being ATP a non-
selective agonist of both P2X and P2Y receptors. ARO
cells were treated with 100 mM UTP or with 100 mM ADP
for 10 min and APE1/Ref-1 amounts were assayed by western
blot analysis performed on nuclear and cytoplasmic extracts
(Figure 2D, lanes 3 and 4). Both UTP and ADP clearly exert a
stimulatory effect, comparable with that obtained with ATP
treatment (Figure 2D, lane 2), thus suggesting that P2Y recept-
ors are mainly involved in the ATP-induced APE1/Ref-1 nuc-
lear translocation. Moreover, the specificity of UTP for P2Y2
receptors (27,28) is suggestive for a major involvement of
P2Y2 over P2Y1 receptors in mediating the effect of ATP.
To strengthen the role of P2Y receptors and to definitely
exclude the involvement of P2X receptor class, experiments
with the specific agonist of P2Y receptors (i.e. 2MeSADP) and
with the specific agonist of P2X receptors (i.e. abMeATP)
were performed (Figure 2D, lanes 5 and 6). While the former
promoted an active APE1/Ref-1 nuclear translocation, the
latter was completely unable.
Further experiments were carried out to discriminate the
different subclasses of P2Y purinoreceptors. Unlike P2Y1
and P2Y1-like receptors, P2Y2 and P2Y4 receptors are activ-
ated by both ATP and UTP and only weakly by ADP and other
nucleoside diphosphates. It is known that P2Y6 receptor is
activated by UDP that, in our experimental conditions, can
be present as a contaminant. To exclude the involvement of
P2Y4 and P2Y6 in our system, we used RT–PCR to assay the
expression of these receptors by ARO cells (Figure 2E, left).
Indeed, while P2Y1 and P2Y2 are expressed, P2Y4 and P2Y6
are not, thus excluding their involvement in the APE1/Ref-1
activation. As a positive control for P2Y4 and P2Y6 ampli-
fications, the cDNA of MG-63 cells expressing these two
purinoreceptors was used as template. The signal obtained
with primers specific for GAPDH was similar in all reactions,
confirming the integrity and amount of cDNA in each sample.
Western blot analysis, performed with specific antibodies
(Figure 2E, right), confirmed the expression of both P2Y1
and P2Y2 receptors as proteins in the ARO cell line. Bands
of 47 kDa in the case of P2Y1 and of 50 kDa in the case of
P2Y2, which were efficiently competed by pre-incubation of
the P2Y1 and P2Y2 antibodies with each specific peptide
(Figure 2E, lane 3), were detected.
The data obtained with ARO cells claim for a major
involvement of P2Y1 and P2Y2 receptors in mediating ATP-
induced APE1/Ref-1 nuclear translocation. However, we can-
not exclude at present the possible involvement of other P2Y
receptors in other cell systems. Similar data were obtained in
other cell systems, i.e. HOBIT osteoblast-like cells and PC-12
neuronal cells (data not shown), reinforcing the general
physiological importance of this kind of activator signalling.
Continuous purinergic triggering is responsible for the
control of the APE1/Ref-1 subcellular levels
In order to test whether basal ATP release is associated to the
control of the subcellular localization and expression of APE1/
Ref-1 protein, we inhibited the possible effects due to auto-
crine triggering of P2 receptors by treating the cells with the
ATP/ADPase apyrase and with the P2 receptor antagonist
suramin for extended times (Figure 2F). Treatment of ARO
cells with 5 U/ml of apyrase (for 24 and 48 h) significantly
reduced both nuclear and cytoplasmic amounts of APE1/Ref-1
protein. Similar data were obtained by treatment with
100 mM suramin. These data unequivocally demonstrate
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that continuous purinergic triggering by extracellular released
ATP is involved in controlling APE1/Ref-1 subcellular levels.
The downregulation of APE1/Ref-1 nuclear and cytoplasmic
levels were not due to degradative pathways induced by altern-
ative triggering by accumulation of AMP or adenosine due to
the apyrase activity, since neither AMP (data not shown) nor
adenosine (shown in Figure 2C, lane 8) played any effect in
controlling APE1/Ref-1 subcellular localization. Quantifica-
tion of the amounts of APE1/Ref-1 protein levels (in terms of
nuclear/cytoplasmic ratio, Rn/c) upon suramin and apyrase
treatments evidenced that, in association to a reduction in
the APE1/Ref-1 expression levels, the nuclear compartment
resulted emptied in a time-dependent manner (Rn/c control:
1.2; Rn/c apyrase 24 h: Rn/c 0.9; Rn/c apyrase 24 h: 0.7; Rn/c
suramin 24 h: 0.45; Rn/c suramin 48 h: 0.3). These data parallel
those obtained by CHX treatment confirming the hypothesis
that P2 triggering is responsible for the maintenance of APE1/
Ref-1 in the nuclear compartment.
APE1/Ref-1 nuclear translocation upon ATP and H2O2
stimulation is Ca2+ and PKC-dependent
Previous studies demonstrated that PKC is able to modulate
APE1/Ref-1 functions (29) and that a Ca2+ ionophore induces
APE1/Ref-1 nuclear translocation in rat FRTL-5 thyroid cells
(30). It is also known that ATP induces both intracellular Ca2+
response and PKC activation (27). We investigated whether
inhibition of these two pathways was able to affect APE1/
Ref-1 nuclear translocation. When the cells were loaded
with the intracellular Ca2+ chelator BAPTA-AM (10 mM)
30 min before and during ATP stimulation, the ATP-
dependent nuclear translocation of APE1/Ref-1 was totally
abolished (Figure 3A, lanes 1–4). Confocal analysis also con-
firmed that BAPTA-AM inhibited APE1/Ref-1 trafficking to
the nucleus (data not shown) demonstrating that intracellular
Ca2+ mobilization regulated ATP-induced APE1/Ref-1
nuclear translocation. In calcium imaging experiments on
fura2-loaded (16) ARO cells, incubation with the intracellular
Ca2+ chelator BAPTA-AM (10 mM, 30 min) totally prevented
the ATP-induced response, indicating that this non-toxic
concentration of the chelator efficiently buffered the Ca2+
rise (data not shown). To investigate PKC involvement, we
downregulated the enzyme by treating the cells overnight with
1 mM phorbol myristate acetate (PMA) (31). The treatment
did not affect the ATP-induced response, in terms of Ca2+
mobilization (data not shown), thus ruling out a major involve-
ment of PKC in Ca2+ rise. Western blot analysis (Figure 3A,
lanes 5–8) clearly demonstrated that, in these conditions, the
ATP-dependent APE1/Ref-1 nuclear translocation was totally
inhibited. Similar results were obtained with the specific PKC
inhibitor bis-indolylmaleimide I, also called GF 109203X (data
not shown) (32). By confocal analysis, we observed that in the
presence of CHX and PMA, APE1/Ref-1 did not translocate to
the nucleus upon ATP stimulation, showing the same amount
of nuclear and cytoplasmic localization present at the steady
state as well as before each ATP addition (data not shown).
Thus, these data clearly demonstrate that intracellular Ca2+
mobilization and PKC activation are independently required
for APE1/Ref-1 trafficking to the nucleus upon P2 triggering
by extracellular ATP.
Previously, we and other groups have observed that ROS
exposure induces the neosynthesis and the translocation of
APE1/Ref-1 from the cytosol to the nucleus of stimulated
cells (1), through a still unknown mechanism. Recently, it
has been demonstrated that H2O2 production can be triggered
by various extracellular stimuli, including G-protein-coupled
or -uncoupled receptors activation (33,34), acting as second
messenger. With the aim of finding the existence of similar-
ities with the ATP-induced APE1/Ref-1 stimulation, we per-
formed a series of experiments by treating cells with H2O2.
Time-course of ARO cells exposed to 1 mM H2O2 indicated
that, similarly to what exerted by exogenous ATP, APE1/
Ref-1 activation is associated to two early mechanisms, neo-
synthesis and its translocation from the cytosol to the nucleus
(data not shown). Then, we investigated the role of intracel-
lular Ca2+ and PKC in H2O2-induced APE1/Ref-1 activation
(Figure 3B). ARO cells were pre-treated overnight with PMA,
Figure 2. Purinergic triggering causes APE1/Ref-1 cytoplasm to nucleus translocation and its maintenance in the nuclear compartment in a protein-neosynthesis
independent manner. (A) ARO cells were cultured in serum-free medium for 48 h and then stimulated or not with ATP for the indicated times and in the presence of the
protein synthesis inhibitor CHX (15 mg/ml) 5 min before and during the ATP treatment. After stimulation, nuclear and cytoplasmic extracts were prepared and
analysed by western blot analysis for the presence of APE1/Ref-1, as described above. Western blot shown is representative of three. Lower panel, values obtained
from densitometric analysis of three independent western blot experiments were reported as histograms. Columns and bars indicate the means ± SD from three
independent experiments. Black bars represent the nuclear levels of APE1/Ref-1 and the white dotted bars represent the cytoplasmic APE1/Ref-1 protein levels
obtained from densitometric analysis of three independent experiments, normalized versus actin (*, p < 0.05; **, p < 0.001 compared with controls). (B) ARO cells
were treated as in (A). Cells were then fixed and stained for APE1/Ref-1 (green). Nuclei were visualized by propidium iodide counterstaining (red). (C). P2 receptor
triggering is responsible for APE1/Ref-1 cytoplasm to nucleus translocation induced by ATP treatment. ARO cells were cultured in serum-free medium for 48 h and
then stimulated with the indicated amounts of ATP for 10 min. Representative western blot analysis, performed as described in Materials and Methods, of APE1/
Ref-1 expression levels of both nuclear and cytoplasmic extracts of ARO cells stimulated or not with decreasing amounts of ATP, as indicated (lanes 2–4). In order to
test whether extracellular ATP activates APE1/Ref-1 translocation by activation of P2 cell-surface purinergic receptors, ARO cells were pre-treated with the specific
P2 receptor antagonist suramin (100 mM) 30 min before the addition of 100 mM ATP (lanes 5 and 6), or with ATP-gS (lane 7) or with adenosine (lane 8) alone.
(D). Stimulation of APE1/Ref-1 nuclear translocation by P2Y triggering in ARO cells. ARO cells were cultured in serum-free medium for 48 h and then stimulated
with the indicated agonists. Representative western blot analysis, performed as described in Materials and Methods, of APE1/Ref-1 expression levels of nuclear and
cytoplasmic extracts of ARO cells is reported. (E). P2 receptors expression by ARO cells. Left panels: PCR amplification of cDNAs with P2Y1, P2Y2, P2Y4, P2Y6
and GAPDH primer pairs. cDNAs were synthesized from RNA template prepared from ARO cells or MG-63 cells, as a positive control. As indicated, the bands of 259
(lane 1, upper part), 362 (lane 2, upper part), 449 and 530 bp (lanes 2, lower part) correspond to amplification products specific for P2Y1 and P2Y2, P2Y4 and P2Y6
receptors cDNA, respectively. As a control of cDNA quality, GAPDH yields a larger 598 bp band. The control reactions contained not retro-transcribed mRNA
instead of template cDNA (lanes 3 and 4). Right panel: western blot analysis of P2Y1 and P2Y2 receptors in ARO cells. Analysis was performed as described in
Materials and Methods. To assay for the specificity of the recognized bands, competition experiments with the specific peptides of the two receptors were performed
by pre-incubating each antibody for 30 min at room temperature with each specific peptide (lane 3). (F). Continuous purinergic triggering controls the subcellular
levels of APE1/Ref-1 in ARO cells. ARO cells were treated with the indicated amounts of the ATP/ADPase apyrase and with the P2 receptor inhibitor suramin for the
indicated times. Representative western blot analysis, performed as described in Materials and Methods, of APE1/Ref-1 expression levels of nuclear and cytoplasmic
extracts of ARO cells is reported.
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to downregulate PKC, and with BAPTA-AM to deplete intra-
cellular Ca2+. After the addition of 1 mM H2O2 for 5 min,
cytosol and nuclear extracts were prepared and assayed by
western blot. We observed that the translocation of APE1/
Ref-1 from cytosol to nucleus was evident in cells stimulated
with H2O2 and in the absence of PMA or BAPTA-AM
(Figure 3B, lanes 5 and 6), while in cells treated with
these inhibitors the translocation was completely inhibited
(Figure 3B, lanes 1–4). These results clearly indicate that,
similarly to what seen for the ATP-triggering, H2O2-induced
translocation of APE1/Ref-1 is also dependent on PKC and
calcium ion. This fact suggests that H2O2 and ATP trigger the
same signal transduction pathway and that a linkage may exist
between oxidative stress and involvement of purinergic-
triggering in controlling cell functioning.
ATP stimulation promotes ROS generation in ARO cells
through NADPH oxidase, which is required for
APE1/Ref-1 cytoplasm to nucleus translocation
It has been recently reported that prostate tumour spheroids
may generate intracellular ROS, upon purinergic triggering, by
a non-phagocytic NADPH oxidase (18). Therefore, since
APE1/Ref-1 is sensitive to intracellular ROS levels, we hypo-
thesized that ATP-induced APE1/Ref-1 translocation in ARO
cells could be mediated by intracellular ROS rise. Thus, we
tested the ability of ARO cells to produce intracellular ROS
upon purinergic triggering. Indeed, incubation of ARO cells
with 100 mM ATP for 10 min significantly increased the levels
of intracellular ROS (Figure 4A), as evidenced by oxidation of
non-fluorescent H2DCF to the highly fluorescent oxidation
product DCF. To test whether the increase of DCF fluores-
cence reflects an elevation of intracellular ROS levels, we pre-
incubated ARO cells with the free radical scavenger N-acetyl
cysteine (NAC). As it is clear from Figure 4A, 10 mM NAC
treatment is able to significantly reduce the relative fluores-
cence indicating that a generation of intracellular ROS does
really occur upon ATP stimulation of the cells.
Several studies indicated a leading role for an NADPH
oxidase in generating intracellular ROS in non-phagocytic
cells (35). To investigate the possible involvement of an
NADPH oxidase in the ATP-mediated ROS generation,
ARO cells were pre-incubated with the specific NADPH
Figure 3. Intracellular Ca2+ mobilization and PKC are involved in APE1/Ref-1 nuclear translocation. (A). ARO cells were cultured in serum-free medium for 48 h
and then stimulated with ATP for the indicated times. Cells were pre-treated with the intracellular Ca2+ chelator BAPTA-AM (10 mM) for 30 min before and during
the stimulation time or PKC activation was abolished by incubating the cells with 1 mM PMA o/n and during the stimulation time. Treatments with BAPTA-AM or
PMA in the absence of ATP addition were used as controls. After stimulation, nuclear and cytoplasmic extracts were prepared and analysed by western blot for the
presence of APE1/Ref-1, as described above. Western blot shown is representative of three. (B). H2O2-induced APE1/Ref-1 cytoplasm to nucleus translocation is
inhibited by intracellular Ca2+ mobilization and PKC activation. ARO cells were cultured in serum-free medium for 48 h and then stimulated with H2O2 for 5 min.
Cells were pre-treated with the intracellular Ca2+ chelator BAPTA-AM (10mM) for 30 min before and during the stimulation time or PKC activation was abolished by
incubating the cells with 1mM PMA o/n and during the stimulation time. Treatments with BAPTA-AM or PMA in the absence of H2O2 addition were used as controls.
After stimulation, nuclear and cytoplasmic extracts were prepared and analysed by western blot analysis for the presence of APE1/Ref-1, as described above. Western
blot shown is representative of three.
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oxidase inhibitor diphenylene iodonium chloride (DPI) (36),
and intracellular ROS levels were monitored by the use of the
ROS indicator H2DCFDA. DPI treatment (Figure 4A) com-
pletely blocked the ATP-induced ROS generation, indicating
the involvement of a non-phagocytic NADPH oxidase in ROS
generation following purinergic receptor triggering.
Here, we have demonstrated that intracellular Ca2+ mobil-
ization upon purinergic triggering by ATP is a fundamental
prerequisite for APE1/Ref-1 cytoplasm to nucleus transloca-
tion. Thus, we tested the involvement of [Ca2+]i rise in ROS
generation. ATP elicits a transient [Ca2+]i increase in ARO
cells (data not shown). When ARO cells were loaded with the
intracellular Ca2+ chelator BAPTA-AM, ROS generation fol-
lowing ATP was completely blunted and the ROS levels
dropped to a value far under the basal level, suggesting that
Ca2+ mobilization is also required for the basal production of
intracellular ROS (Figure 4A). The intracellular Ca2+ mobil-
ization, as followed by calcium imaging experiments on fura2-
loaded ARO cells, was not abolished in the presence of NAC,
suggesting that it does not depend on the generation of intra-
cellular ROS (data not shown). Thus, we can conclude that
Ca2+ mobilization seems to be the most important regulatory
mechanism able to control the intracellular ROS production of
ARO cells. We, therefore, tested the role of NADPH oxidase
with respect to ATP-mediated APE1/Ref-1 cytoplasm to nuc-
leus translocation (Figure 4B). We performed experiments of
ATP stimulation in cells pre-treated with CHX (15 mg/ml) in
order to follow only the translocation event of APE1/Ref-1.
Indeed, APE1/Ref-1 translocation is completely prevented by
treatment of the cells with the NADPH oxidase inhibitor DPI
and the ROS scavenger NAC. Therefore, ATP-induced APE1/
Ref-1 translocation requires active production of intracellular
ROS by an NADPH oxidase.
The non-phagocytic NADPH oxidase has been previously
demonstrated to be activated by Ca2+-activated phospholipase
A2 (PLA2) (18). In order to investigate whether this is also the
case in our cell system and whether it is related to APE1/Ref-1
translocation, ARO cells were pre-incubated with PLA2 inhib-
itor indomethacin, and ROS generation and APE1/Ref-1
translocation were analysed (Figure 4C and D, respectively).
Indeed PLA2 inhibition was responsible for blockage of
ROS production together with a partial, though significant,
inhibition of APE1/Ref-1 cytoplasm to nucleus translocation
(Figure 4D, lanes 5 and 6).
It has been previously demonstrated, in several cell systems,
that extracellular regulated kinases (ERKs) contribute to func-
tionally activate the NADP(H) oxidase by phosphorylating
different subunits (37,38). In order to check whether
ERK-1/2 may also be involved in ATP-induced activation
of ROS production and APE1/Ref-1 translocation, both phe-
nomena were analysed. Data are reported in Figure 4C and D.
PD98059 (a specific inhibitor of ERK-1/2 phosphorylation)
pre-treatment was able to both block intracellular ROS
production (Figure 4C) and APE1/Ref-1 cytoplasm to nucleus
translocation (Figure 4D, lanes 3 and 4). Therefore, ERKs
signalling is also responsible for the activation of intracellular
ROS production by ATP stimulation.
Inhibition of intracellular Ca2+ mobilization and ROS
production block APE1/Ref-1 nuclear translocation
and its functional activation
In order to test whether the stimulatory effect of ATP treat-
ment has consequences on APE1/Ref-1 functions, we first
tested its DNA repair activity. APE1/Ref-1 enzymatic activ-
ities, on nuclear extracts from ARO cells stimulated or not
with extracellular ATP, were assayed, as described previously
(6). The assay uses a radiolabelled oligonucleotide (26mer)
containing an artificial tetrahydrofuran AP site which, when
cleaved by AP endonuclease, produces a labelled 14mer. The
same amounts of nuclear extracts from non-stimulated and
ATP-stimulated ARO cells were assayed for endonuclease
activity and are shown in Figure 5A. The increased nuclear
accumulation of APE1/Ref-1 upon 10 min of ATP stimulation
was paralleled by an increasing AP endonuclease activity, as
measured with the oligonucleotide cleavage assay (Figure 5A,
compare lane 4 with lane 3). In order to test the role of intra-
cellular Ca2+ mobilization and ROS generation on APE1/
Ref-1 DNA repair functions, we measured the effects of
BAPTA-AM and DPI on APE1/Ref-1 enzymatic activities,
by using the same assay. As it is evident from Figure 5A,
when cells were pre-treated with BAPTA-AM (lane 5) or
DPI (lane 6), the increase in APE1/Ref-1 cleavage activity
upon ATP stimulation was completely prevented.
In order to test whether APE1/Ref-1 activation following
ATP stimulation has a functional relevance as a redox modu-
lator, the activity of the well-established redox-regulated tran-
scription factor AP-1 was assessed. ARO cells were treated
with CHX as described above and further stimulated for 10 min
with 100 mM ATP. Then, nuclear extracts were prepared and
assayed for AP-1 DNA-binding activity by EMSA analysis
(Figure 5B). Early time stimulation by ATP is able to signi-
ficantly enhance the DNA-binding activity of AP-1, demon-
strating a 3-fold increase in specific DNA-binding activity
(compare lane 2, unstimulated, and lane 3, stimulated). To
test the causal role of APE1/Ref-1 in the ATP-induced
Figure 4. ATP-induced APE1/Ref-1 nuclear translocation is dependent on ROS produced by ARO cells. (A). Elevation of intracellular ROS following treatment of
ARO cells with ATP is inhibited by free radical scavenger and depends on the activation of non-phagocytic NADPH oxidase in a Ca2+-dependent manner. ARO cells
were cultured in serum-free medium for 48 h and then stimulated with ATP for 10 min. Oxidation of non-fluorescent H2DCF to fluorescent DCF was followed as
indirect measure of intracellular ROS levels. After incubation of ARO cells for 10 min with ATP, the amount of fluorescent DCF was monitored. In inhibitory
experiments, ARO cells were pre-incubated with either 10 mM NAC (2 h), 10mM DPI (10 min) or 10mM BAPTA-AM (30 min) before ATP treatment. Subsequently,
the DCF fluorescence was monitored, as above (Statistical analysis by ANOVA *, p < 0.05; **, p < 0.001). (B). Rise in intracellular ROS levels is responsible for
ATP-induced APE1/Ref-1 nuclear translocation. ARO cells were treated as in (A). After stimulation, nuclear and cytoplasmic extracts were prepared and analysed by
western blot analysis for the presence of APE1/Ref-1 and actin, as described above. Western blot shown is representative of three. (C). Activation of intracellular ROS
production upon ATP stimulation by NADPH oxidase is dependent on ERKs phosphorylation and PLA2. ARO cells were cultured in serum-free medium for 48 h and
then stimulated with ATP for 10 min. In inhibitory experiments, ARO cells were pre-incubated for 1 h with either 10 mM indomethacin as PLA2 inhibitor or 30 mM
PD98059, as ERK-1/2 phosphorylation inhibitor; the cells were then incubated for 10 min with 100 mM ATP. ROS levels were monitored as described above
(Statistical analysis by ANOVA *, p < 0.05; **, p < 0.001). (D). APE1/Ref-1 nuclear translocation is dependent on activation of ERK-1/2 and PLA2. ARO cells
were treated as in (C). After stimulation, nuclear and cytoplasmic extracts were prepared and analysed by western blot analysis for the presence of APE1/Ref-1 and
actin, as described above. Western blot shown is representative of three.
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Figure 5. Inhibition of intracellular Ca2+ mobilization and ROS production blocks APE1/Ref-1 nuclear translocation and its functional activation. (A). Left:
blockage of intracellular Ca2+mobilization and ROS production prevents early activation of base excision repair activity of APE1/Ref-1 upon ATP stimulation. ARO
cells were cultured in serum-free medium for 48 h and then stimulated with ATP for 10 min. To blunt the effects of Ca2+ signals, cells were treated with the
intracellular Ca2+ chelator BAPTA-AM and to block the intracellular ROS production, cells were treated with DPI. Thereafter, cells were treated for 10 min with
100 mM ATP. Lane 1, oligonucleotide alone. Lane 2, endonuclease activity of recombinant APE1/Ref-1 (5 ng) as a positive control. Lane 3, endonuclease activity of
50 ng of unstimulated ARO cells. Lane 4, endonuclease activity of 50 ng of stimulated ARO cells. Lane 5, endonuclease activity of 50 ng of stimulated ARO cells after
pre-treatment with BAPTA-AM (10mM) for 30 min. Lane 6, endonuclease activity of 50 ng of stimulated ARO cells after pre-treatment with DPI (10mM) for 10 min.
For simplicity, only a dose, from a scalar dilution experiment, of nuclear extract is reported. Right: values representing the relative endonuclease activity of
endogenous APE1/Ref-1 were reported as histograms and reflect the percentage of cleavage of the radiolabelled AP site-containing oligonucleotide. Columns and
bars indicate the means ± S.D. of three different experiments (*, p < 0.05 compared with controls by Student’s t-test). (B). Left: blockage of intracellular Ca2+
mobilization and ROS production prevents early activation of AP-1 binding activity upon ATP stimulation dependent on APE1/Ref-1. To blunt the effects of Ca2+
signals and intracellular ROS generation, cells were treated with BAPTA-AM (lanes 4 and 5) and with DPI (lanes 6 and 7) as described in A, respectively. Thereafter,
cells were treated for 10 min with 100 mM ATP. Then, cells were collected and lysed to obtain nuclear extracts that were subsequently used for EMSA analysis with
the 32P-labelled specific oligo called AP-1 BS. An aliquot of 5mg of each nuclear extract was incubated with 200 fmol of labelled probe in the presence of 500 ng of calf
thymus DNA as aspecific competitor for 30 min at room temperature and then analysed by native 5% PAGE. After drying, the gel was exposed o/n at 80C for
autoradiography. To test for the specific protein/DNA complex, a competition assay was performed, on ATP-stimulated nuclear extracts, with a molar excess of the
cold specific AP-1 BS (lane 8) and with a mutant binding site called AP-1 MS (lane 9). In order to test for the real involvement of APE1/Ref-1 in the blockage of the
ATP-induced AP-1 DNA-binding activity exerted by both BAPTA-AM and DPI, nuclear extracts from the ATP-stimulated cells treated with the inhibitors were
re-added of 0.5mg of recombinant purified APE1/Ref-1 protein (rAPE1/Ref-1) (lanes 5 and 7). Lane 1 represents the oligonucleotide alone; lane 2 represents the AP-1
DNA-binding activity in basal conditions; lane 3 represents the AP-1 DNA-binding activity of ATP-treated ARO cells. Data are representative of three independent
experiments. Right: values representing the relative DNA-binding activity of AP-1 were reported as histograms. Columns and bars indicate the means ± SD of three
different experiments (*, p < 0.05 compared with controls by Student’s t-test). (C). Protection by ATP of H2O2-evoked cell death in ARO cells. ARO cells were pre-
incubated with ATP (100 mM) for 30 min and then exposed to various concentrations of H2O2 for 1 h. Protein neosynthesis was blocked by pre-treatment of the cells
for 5 min with CHX (15 mg/ml) and for the whole duration of the experiment. The cell viability was evaluated by the MTT assay. The plots show mean ± S.D. of
triplicate measurements. Values were normalized to total cell number (basal) and the cell viability was expressed as percentage of total cell. Asterisks show significant
differences from the control response (*p ¼ 0.011, **p ¼ 0.0221, Student’s t-test).
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AP-1 DNA-binding activity induction, we performed
experiments by using an APE1/Ref-1 immunodepletion/
reconstitution assay (data not shown) (39). These data suggest
that, indeed, APE1/Ref-1 nuclear translocation acts as a
physiological activator of AP-1 DNA-binding activity in
response to ATP treatment of ARO cells, thus providing a
molecular explanation for the early activation of AP-1
DNA-binding activity demonstrated in several cell types
upon purinergic triggering (14,15).
Then, we tested whether activator pathways leading to
APE1/Ref-1 translocation (i.e. Ca2+ mobilization and intracel-
lular ROS production) by ATP have a functional relevance, in
terms of co-activator role on AP-1. ARO cells were treated in
the presence of CHX as described above, stimulated for 10 min
with 100 mM ATP in the presence of inhibitors of APE1/Ref-1
translocation (DPI and BAPTA-AM). Nuclear extracts were
prepared and assayed for AP-1 DNA-binding activity by EMSA
analysis (Figure 5B, lanes 4–7). Indeed, blocking the intracel-
lular calcium mobilization by BAPTA-AM pre-treatment
substantially prevents the ATP-induced activation of AP-1
DNA-binding activity (compare lane 4 with lane 3). The exo-
genous application of 0.5 mg of recombinant purified APE1/
Ref-1 (rAPE1/Ref-1) to the nuclear extract from BAPTA-
AM-treated cells efficiently restored the ATP-induced AP-1
DNA-binding activity (lane 5), demonstrating that the block-
age due to the intracellular calcium chelator is exerted by
means of APE1/Ref-1. Similar results were obtained when
cells were pre-treated with the NADPH-oxidase inhibitor
DPI (lanes 6 and 7). These results clearly demonstrate that
either inhibition of intracellular ROS production or Ca2+
mobilization is able to prevent AP-1 stimulation induced
by ATP by means of APE1/Ref-1 nuclear translocation.
Therefore, we can conclude that the two well-known APE1/
Ref-1 functions (as a DNA repair enzyme and as a redox
co-activator) are exerted by ATP stimulation through
APE1/Ref-1 nuclear translocation.
Protection by ATP of H2O2-evoked cell death in
ARO cells
It is commonly accepted that APE1/Ref-1 functional activa-
tion is required for protecting cells from oxidative injuries
(1,40). Moreover, it has been recently demonstrated that over-
expression of APE1/Ref-1 is able to prevent the H2O2-induced
cell death in different cells systems (41,42). Therefore, we
tested whether ATP stimulation was able to protect cells by
H2O2-evoked cell death. ARO cells were stimulated or not for
30 min with 100 mM ATP, in the presence of CHX (15 mg/ml),
and treated for an additional 1 h with increasing amounts of
H2O2, and cell viability was then assayed by MTT analysis
(Figure 5C). H2O2 treatment caused a concentration-
dependent decrease in cell viability of ARO cells, due to cell
death. When incubated for 1 h with 5 mM H2O2, the cell
viability was almost halved and then gradually decreased to
20% of the non-treated control level. Figure 5C shows
that pre-treatment with ATP significantly reduced the H2O2-
induced cell death exerted at 2 and 5 mM dose of H2O2.
Therefore, these data reinforce the functional relevance of
our findings on APE1/Ref-1, suggesting that activation of
APE1/Ref-1 by extracellular ATP is associated to a protection
towards H2O2-induced cell death exerted by purinergic
triggering. Further experiments are in progress to demonstrate
the causal involvement of APE1/Ref-1 activation in ATP-
induced protection to H2O2 treatment.
DISCUSSION
The present study was undertaken to investigate whether
the activation of P2 receptors by extracellular nucleotides is
involved in the regulation of signal transduction mechanisms
leading to APE1/Ref-1 activation. The results demonstrate that
extracellular ATP stimulates a Ca2+-dependent ROS produc-
tion pathway ultimately leading to (i) activation of APE1/
Ref-1 cytoplasm to nucleus translocation and maintenance
in the nuclear compartment in a protein-neosynthesis inde-
pendent manner (occurring at very early times upon stimula-
tion, i.e. within 10 min) and (ii) stimulation of its expression at
later times (30 and 60 min). The early increase in nuclear
accumulation is well paralleled by a functional activation of
APE1/Ref-1 as a DNA repair enzyme over abasic sites, and as
a redox co-activator of AP-1 DNA-binding activity. These
results suggest a likely explanation of the molecular mechan-
isms at the basis of the protective role exerted by ATP
stimulation of ARO cells against H2O2-induced cell death.
Obviously, the causal role of APE1/Ref-1 nuclear accumula-
tion upon purinergic triggering in controlling these biological
effects should be demonstrated. However, at present, this is
impossible since it would require a dominant-negative form of
the protein able to inactivate the nuclear translocation of the
endogenous APE1/Ref-1 protein. Unfortunately, at present,
the molecular mechanisms responsible for regulating APE1/
Ref-1 cytoplasm to nucleus translocation are poorly under-
stood (i.e. post-translational modifications, interaction with
shuttling proteins, etc.). Conversely, the importance of
APE1/Ref-1 intracellular levels in controlling cell prolifera-
tion and DNA repair has been already well documented by
different works using gene silencing techniques (41–43). A
very recent paper shed some lights showing that APE1/
Ref-1 nuclear translocation is an active process involving
Karyopherin 2a (44). These authors also showed the existence
of nuclear export process responsible for regulating the APE1/
Ref-1 nuclear level. In light of our data, showing that
P2-induced signalling plays an important role in controlling
nuclear maintenance of the protein, we can hypothesize that
this process could be an inhibitory target of P2 pathway here
delineated.
We have characterized the mechanisms responsible for the
activatory effects on APE1/Ref-1 and found that purinergic
signalling is mainly exerted by intracellular ROS production
by non-phagocytic NADPH oxidase in a calcium-dependent
manner; however, additional MAPK- and/or PKC-dependent
mechanisms could also be involved (see Figure 6). The
involvement of NADPH oxidase in the activation of APE1/
Ref-1 suggests the existence of an autoregulatory loop
between these two proteins. In fact, the non-phagocytic
NADPH oxidase is an enzyme composed of multiple
membrane-associated (Mox and p22phox) and cytosolic com-
ponents (p67phox, p47phox, Rac1) and catalyses the transforma-
tion of the molecular oxygen to the superoxide anion by
transferring an electron from the substrates NADH or
NADPH (45). Moreover, in thyroid cells, it represents the
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major source of H2O2 necessary for thyroid hormone biosyn-
thesis (46). Functional activation of this enzyme is controlled
by Rac1, a small GTPase exerting regulatory and assembling
functions on the oloenzyme itself (47). It has been recently
demonstrated that APE1/Ref-1 may inhibit Rac1 activity
in vivo, in different cell models, thus controlling intracellular
ROS production (48,49). Therefore, we can hypothesize that
APE1/Ref-1 may also be involved in extinguishing the
NADPH-mediated ROS production induced by P2Y triggering
(see Figure 6). Work is in progress to address this issue. Since
APE1/Ref-1 and NADPH oxidase are ubiquitously expressed,
and purinergic triggering is particularly important for endo-
thelial, fibroblastic and smooth muscle cells in the vascular
system (50), the present findings may be therapeutically
relevant.
At present, receptors for ATP and other nucleotides have
been found in almost all cell types and have wide physio-
logical involvement both in normal and in pathological
conditions. Though the effects of extracellular nucleotides
in endocrine cells are largely unexplored and even if the thyr-
oid gland is mainly regulated by thyrotropin, it is also under
regulation by sympathetic and parasympathetic nerves, whose
terminals also reach thyroid follicles (51). Therefore, in prin-
ciple, ATP released from nerve terminals may also modulate
thyroid functions. In particular, investigations in thyroid cell
cultures have shown that ATP may act as true agonist being
involved in some physiological responses, such as regulation
of iodide fluxes and generation of H2O2 (52) and may act as
co-mitogen in normal rat FRTL-5 thyroid cell lines (15)
through up-regulating the expression of proto-oncogenes,
such as c-Fos and the enhancement of DNA-synthesis (53).
In thyroid cells, the molecular mechanism of such activations
described a central role for Ca2+ fluxes evoked by ATP and
activation of PLA2 as consequences of the ATP-induced
stimulation of phospholipase C. However, the effects of the
interactions of these two pathways, in terms of molecular
targets, have not yet been thoroughly investigated in thyroid
cells. Interestingly, very recent data demonstrated that trans-
formed thyroid cell lines show disturbances in purinergic Ca2+
signalling (54). Whether alteration in purinergic signalling
plays a role in tumourigenic process is unknown, at present.
Our data, obtained under continuous treatment with apyrase
and suramin, showed that purinergic triggering is responsible
for the maintenance of high cytoplasmic levels of APE1/Ref-1
protein in the anaplastic tumoural thyroid ARO cell line. These
data, together with the observation that ATP stimulation
exerts protective role on H2O2-induced cell death, provide
two important suggestions: (i) alterations of the intracellular
amounts of APE1/Ref-1 found in several tumours, including
thyroid tumours (1), may be due to an imbalance in purinergic
receptor signalling system and (ii) purinergic receptors altera-
tions may be an early event occurring during the tumourigenic
process and may provide the tumour cell with higher protect-
ive mechanisms towards oxidative injuries. In this light, much
more attention should be paid in order to better understand the
role, if any, of purinergic receptor signalling in controlling
specific differentiative steps, as recently demonstrated by the
finding that a coordinated expression of several purinergic
receptors of different classes occur during skeletal muscle
development (55).
Figure 6. Model of the activatory role of purinergic triggering on APE1/Ref-1 subcellular localization and functions.
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